BERKELEY, CA (UroToday.com) - In the present review article, we depict the significant advances made in the diagnosis and management of penile cancer. This often aggressive tumor type is often characterized by an underlying poor prognosis, mostly attributable to its late clinical presentation and heterogeneity of surgical care due to the paucity of cases treated at most centers.
The management of penile cancer has evolved in recent years with the adoption of penile-sparing and minimally-invasive surgical approaches to the inguinal lymph nodes which are a frequent site of regional spread for this malignancy.
We emphasize the importance of adopting a multimodal approach consisting of neoadjuvant systemic chemotherapy (with or without external beam radiotherapy) followed by consolidative surgical resection in patients presenting with bulky/locally advanced nodal metastases from penile cancer.
The clinical pearls and principles in this review may ultimately result in improved cancer-specific outcomes while minimizing treatment-related morbidity.
Written by:
Philippe E. Spiess, MD, MSc, FACS, FRCS(C) as part of Beyond the Abstract on UroToday.com. This initiative offers a method of publishing for the professional urology community. Authors are given an opportunity to expand on the circumstances, limitations etc... of their research by referencing the published abstract.
Department of Genitourinary Oncology, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL USA 33612
Current concepts in penile cancer - Abstract
More Information about Beyond the Abstract